Skip to main content
Article
A Case of Medication-Induced Diffuse Alveolar Hemorrhage in Neurofibromatosis Type 1
West Florida Division GME Research Day 2020
  • Ashar Mahmood, HCA Healthcare
  • Liz Palmer, HCA Healthcare
  • Rebecca Schuyler, HCA Healthcare
  • Svitlana Sharpovalova
  • Bilal Nadeem, HCA Healthcare
  • Mukesh Mehta
  • Salman Muddassir, HCA Healthcare
  • Nikolay Mitzov, HCA Healthcare
  • Monicka S Felix, HCA Healthcare
Division
West Florida
Hospital
Oak Hill Hospital
Specialty
Internal Medicine
Document Type
Poster
Publication Date
5-1-2020
Keywords
  • case report,
  • Neurofibromatoses,
  • hemorrhage,
  • anticoagulants
Abstract

  • Amiodarone, an antiarrhythmic and apixaban, an anticoagulant have been associated with diffuse alveolar hemorrhage (DAH).
  • Cases have been documented demonstrating DAH in the setting of amiodarone and apixabantreatment, however there are few cases examining DAH in combination therapy.
  • We present a case of diffuse alveolar hemorrhage in the setting of amiodarone and apixaban treatment for paroxysmal atrial fibrillation.
  • NF1 is know to have higher risk for major bleeds due to their friable vasculature.

Citation Information
Ashar Mahmood, Liz Palmer, Rebecca Schuyler, Svitlana Sharpovalova, et al.. "A Case of Medication-Induced Diffuse Alveolar Hemorrhage in Neurofibromatosis Type 1" (2020)
Available at: http://works.bepress.com/monicka-felix/2/